235
Participants
Start Date
June 30, 2017
Primary Completion Date
April 30, 2021
Study Completion Date
January 30, 2023
SIB
patients will recieve twice-daily radiotherapy by simultaneous integrated boosting technique concurrent with chemotherapy
Standard
patients will recieve standard twice-daily radiotherapy concurrent with chemotherapy
Beijing Cancer Hospital, Beijing
Sun Yat-sen University
OTHER
Fudan University
OTHER
Xijing Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Jilin Provincial Tumor Hospital
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Air Force General Hospital of the PLA
OTHER_GOV
China-Japan Friendship Hospital
OTHER
Peking University Third Hospital
OTHER
Peking Union Medical College Hospital
OTHER
Beijing Hospital
OTHER_GOV
Beijing Chao Yang Hospital
OTHER
Peking University People's Hospital
OTHER
Peking University First Hospital
OTHER
Anhui Shi, MD
OTHER